Deals channel feed – Endpoints News

Deals channel feed

Novartis highlights overall M&A track record following MorphoSys impairment

7 months ago

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

7 months ago

Paragon launches another company in hot PD-1xVEGF space that goes straight to reverse merger

7 months ago

Corrected: Genmab lines up T cell engager pact with Revitope

7 months ago

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

7 months ago

AbbVie makes $1.4B acquisition of Alzheimer's biotech

7 months ago

Novartis pays Monte Rosa $150M for Phase 1 drug in latest endorsement of molecular glues

7 months ago

Lyell Immunopharma to acquire ImmPACT Bio, cut top programs

7 months ago

Roche returns to Dyno for its AAV tech with $50M upfront

7 months ago

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

7 months ago

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

7 months ago

Samsung Bio inks largest deal yet worth $1.24B with unnamed Asian pharma

7 months ago

Roche, Genentech end anti-tau Alzheimer’s drug collaboration with UCB

7 months ago

Consumer and union groups call on FTC to ‘challenge’ Novo-Catalent deal

7 months ago

Novartis pays $70M upfront to license Chinese biotech’s antitumor drug

7 months ago

Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M

7 months ago

Takeda parts ways with Wave Life Sciences even with Huntington’s trial win

7 months ago

Pfizer partners with molecular glue startup Triana in $49M upfront deal

7 months ago

Eli Lilly reveals £279M investment in the UK through new government deal

7 months ago

Bausch + Lomb's stock rises following report of potential bid from private equity firms TPG and Blackstone

7 months ago

Updated: Lundbeck makes $2.6B cash move for Longboard a month after starting Phase 3 in Dravet syndrome

7 months ago

Catalent sells New Jersey plant to Belgian CDMO, plans moving HQ elsewhere

7 months ago

Sanofi lands on private equity firm CD&R as potential buyer of consumer health unit

7 months ago

Eli Lilly inks another obesity pact, doubling down on small Swiss partner

7 months ago

First page Previous page 8 9 101112 13 14 Next page Last page